How intellectual property works in Canadian research partnerships

By GrantHub Research Team · · Lire en français

How intellectual property works in Canadian research partnerships

If your business partners with a Canadian university or hospital, intellectual property (IP) can make or break the deal. Who owns the results? Who can sell them? In Canada, IP rules are not set by one national law for research partnerships. They are set by contracts, funder rules, and institutional policies—especially in hospitals like Kingston General Hospital (KGH) that operate inside public health and academic systems.

Canadian research partnerships are common in health, life sciences, engineering, and digital health. Hospitals and universities provide research staff and facilities. Companies provide funding and help turn ideas into products. IP rules determine how each partner benefits from the results.


IP ownership is contractual, not automatic

In Canada, IP created during a research collaboration is usually governed by a research agreement. There is no default rule that says the university or hospital owns everything.

Most agreements define:

  • Background IP: IP each party brings into the project.
  • Foreground IP: IP created during the project.
  • Improvements: Enhancements to existing IP.

Ownership of foreground IP can be:

  • The institution may own the IP by itself.
  • The company may own the IP by itself.
  • Both the institution and the company may own the IP together (joint ownership).
  • One party may own the IP, but the other receives a licence to use it.

Hospitals affiliated with universities—such as Kingston General Hospital—often follow university-aligned IP policies but negotiate on a project-by-project basis.


Hospitals prioritize patient care, ethics, and public benefit

Research hospitals operate under strict ethical and public-interest mandates. This affects IP in three key ways:

  • Publication rights: Hospitals usually keep the right to publish results, with short review periods (often 30–90 days) for IP protection.
  • Clinical data controls: Patient data is tightly regulated. IP agreements will limit how data-derived inventions can be used.
  • Reasonable access clauses: Some hospitals require that resulting technologies remain accessible to the health system.

These factors are especially relevant for clinical trials, diagnostics, and medical devices.


Grant funding can override your default IP deal

Many research partnerships rely on public funding. These funders often impose IP conditions.

Examples of Canadian partnership programs that connect businesses with hospitals and universities include:

  • St. Joseph’s Healthcare Hamilton partnership program
    Focuses on access to research expertise, facilities, and IP rather than direct cash funding. IP ownership is typically negotiated in the collaboration agreement.

  • Montreal Neurological Institute-Hospital partnership model
    Provides industry access to clinical research environments, with IP terms defined contractually and matched to institutional innovation policies.

  • OCAD University industry research partnerships
    Often used for applied research and prototyping, with flexible IP structures depending on sponsor contribution.

These programs do not automatically grant IP to businesses. You must review both the funder terms and the institution’s policies before signing.

If you need to filter partnership programs by province, sector, or institution, tools like GrantHub’s eligibility matcher can help you save time.


Common IP structures in hospital–industry partnerships

In Canadian hospital–industry research partnerships, these models are most common:

  • Company-owned IP with licence back
    You own the IP. The hospital gets a non-exclusive licence for research and teaching.

  • Institution-owned IP with commercial licence
    The hospital owns the IP. Your business gets an exclusive or non-exclusive licence, often with milestone or royalty terms.

  • Joint ownership
    Both parties own the IP. This sounds fair but often creates future commercialization challenges.

  • Option-to-license
    The hospital owns the IP initially. Your business has a time-limited option to negotiate a commercial licence.

Hospitals usually avoid structures that restrict future patient care or research use.


Kingston General Hospital–style partnerships: what to expect

While specific IP terms vary by project, hospital-based research centres like Kingston General Hospital typically require:

  • Clear separation of background and foreground IP.
  • Defined commercialization rights for industry partners.
  • Protection of patient data and clinical protocols.
  • Support for academic publication standards.

Expect IP negotiations to involve the hospital’s research services office and, in many cases, a university technology transfer office.


Common mistakes to avoid

  1. Assuming payment equals ownership
    Funding a project does not automatically give you IP rights. Ownership must be written into the agreement.

  2. Ignoring publication clauses
    If your product depends on secrecy, publication timelines matter. Negotiate review periods early.

  3. Accepting joint ownership without a plan
    Joint IP can block future investment if commercialization rights are unclear.

  4. Overlooking funder IP rules
    Public funding programs may limit exclusivity or require Canadian commercialization benefits.


Frequently Asked Questions

Q: Do Canadian hospitals automatically own IP created in research partnerships?
No. IP ownership is negotiated in the research agreement. Hospitals often start with institutional ownership but are open to licensing or assignment depending on the project.

Q: Can my startup own IP developed with a hospital like Kingston General Hospital?
Yes, in some cases. This usually requires strong justification, clear commercialization plans, and protections for patient care and research use.

Q: Are royalties always required when licensing hospital IP?
Not always. Some agreements use milestone payments, equity, or time-limited exclusivity instead of royalties.

Q: Does grant funding reduce my control over IP?
It can. Many public funders require reasonable access, Canadian benefit, or non-exclusive research licences.

Q: How long does IP negotiation usually take?
For hospital partnerships, IP negotiations often take several weeks to a few months, depending on complexity and ethics approvals.


Next steps

Research partnerships with hospitals can help you test your ideas and build trust—but only if the IP structure fits your business goals. Before you engage, map your path to bringing new products to market and your funding sources. GrantHub tracks hundreds of active Canadian partnership and research grant programs, making it easier to find programs that support your IP and business goals.

See also:

  • How to Use ExploreIP to Find Licensable Canadian Intellectual Property
  • How to Find R&D Partners Using Canada’s Research Facilities Navigator
  • How Businesses Can Use NRC Research Facilities for Testing and Validation

Was this article helpful?

Rate it so we can improve our content.

Canada Proactive Disclosure Data

400,000+ Companies Like Yours Have Received Billions in Grants

The Canadian government has funded over 400,000 businesses through 1.27 million grants and contributions. Check your eligibility in 60 seconds.